Fidelity Investments’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,880
| Closed | -$200K | – | 5821 |
|
|
2024
Q2 | $200K | Sell |
4,880
-1,787,470
| -100% | -$74.4M | ﹤0.01% | 3027 |
|
|
2024
Q1 | $75.8M | Sell |
1,792,350
-7,899,501
| -82% | -$332M | 0.01% | 1166 |
|
|
2023
Q4 | $411M | Sell |
9,691,851
-13,931,293
| -59% | -$400M | 0.03% | 473 |
|
|
2023
Q3 | $516M | Buy |
23,623,144
+129,355
| +0.6% | +$3.24M | 0.04% | 377 |
|
|
2023
Q2 | $747M | Buy |
23,493,789
+26,531
| +0.1% | +$814K | 0.06% | 285 |
|
|
2023
Q1 | $572M | Buy |
23,467,258
+50,126
| +0.2% | +$1.47M | 0.05% | 365 |
|
|
2022
Q4 | $739M | Buy |
23,417,132
+101,567
| +0.4% | +$2.87M | 0.07% | 267 |
|
|
2022
Q3 | $659M | Buy |
23,315,565
+1,072,181
| +5% | +$31.9M | 0.07% | 274 |
|
|
2022
Q2 | $588M | Buy |
22,243,384
+39,383
| +0.2% | +$1.12M | 0.06% | 320 |
|
|
2022
Q1 | $777M | Buy |
22,204,001
+2,694,188
| +14% | +$78.7M | 0.06% | 302 |
|
|
2021
Q4 | $633M | Buy |
19,509,813
+703,184
| +4% | +$24.8M | 0.05% | 372 |
|
|
2021
Q3 | $555M | Buy |
18,806,629
+9,969,568
| +113% | +$280M | 0.04% | 401 |
|
|
2021
Q2 | $226M | Buy |
8,837,061
+3,724,661
| +73% | +$53.3M | 0.02% | 768 |
|
|
2021
Q1 | $70.2M | Buy |
5,112,400
+798,700
| +19% | +$11.7M | 0.01% | 1229 |
|
|
2020
Q4 | $71.5M | Buy |
+4,313,700
| New | +$56M | 0.01% | 1175 |
|